SCHEMBL23966827

SCHEMBL23966827

CCOC(=O)CN1CC(n2nc(Cc3nc4cc(OCC(F)F)c(C#N)cc4n3SF)c3ccccc3c2=O)C1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
S1PR2 O95136 4/20 0.36
L3MBTL1 Q9Y468 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PGR P06401 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
CASR P41180 1/20 0.31
PIK3CD O00329 1/20 0.30
TDP1 Q9NUW8 2/20 0.30
ALDH1A1 P00352 1/20 0.30
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23908980 0.86 S1PR2 (0.34) S1PR2L3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL23915196 0.86 S1PR2 (0.33) S1PR2L3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL23966551 0.85 S1PR2 (0.37) S1PR2
SCHEMBL23966573 0.83 BTK (0.35) S1PR2PIK3CD
SCHEMBL23914723 0.82 PGR (0.33) S1PR2L3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL23914725 0.82 PGR (0.32) S1PR2L3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL23915356 0.79 S1PR2 (0.39) S1PR2
SCHEMBL23966577 0.78 S1PR2 (0.38) S1PR2
SCHEMBL23966578 0.76 S1PR2 (0.44) S1PR2
SCHEMBL23908868 0.75 S1PR2 (0.61) S1PR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649119-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2021-11-03 EP disclosed